±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1262  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

zhuimenglx

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúÒ½Ò©ÀàÎÄÕÂÕªÒªµÄ·­Ò룬ººÒëÓ¢£¬·Ç³£¸Ðл£¡

ѪÇåÖ×Áö±êÖ¾ÎïÔڷΰ©¸¨ÖúÕï¶ÏÖеÄÓ¦ÓÃ
Ä¿µÄ
̽ÌÖ5ÖÖѪÇåÖ×Áö±êÖ¾ÎïÔڷΰ©¸¨ÖúÕï¶ÏÖеÄÓ¦ÓüÛÖµ£¬²¢Ñ¡Ôñ×îÀíÏëµÄѪÇåÖ×Áö±êÖ¾Îï×éºÏ¡£
·½·¨
Ó¦ÓÃøÁªÃâÒßÎü¸½ÊµÑé(EL1SA)¼ì²â170Àý·Î°©»¼Õß¡¢50Àý½¡¿µÈ˺Í60Àý·Î²¿Á¼ÐÔ¼²²¡»¼ÕßѪÇåÖÐÉñ¾­ÔªÌØÒìÐÔÏ©´¼»¯Ã¸(NSE)¡¢Î¸ÃÚËØÊÍ·ÅëÄǰÌå(pro-GRP)¡¢Ï¸°û½Çµ°°×l9(CYFRA21¡ª1)¡¢p53¿¹ÌåºÍ°©Åß¿¹Ô­(CEA)µÄˮƽº¬Á¿¡£
½á¹û
·Î°©»¼ÕßµÄ5ÖÖѪÇåÖ×Áö±êÖ¾Îïˮƽ¾ùÃ÷ÏÔ¸ßÓÚ½¡¿µÈË×éºÍ·Î²¿Á¼ÐÔ¼²²¡×飬²îÒìÓÐͳ¼ÆÑ§ÒâÒå(P<0£®01)¡£NSE¡¢pro-GRPÔÚСϸ°û·Î°©ÖеÄˮƽÃ÷ÏÔ¸ßÓÚÆäËûÀàÐ͵ķΰ©(P<0£®01)£¬CYFRA21¡ª1ÔÚÁÛ°©ÖеÄˮƽÃ÷ÏÔ¸ßÓÚÆäËûÀàÐ͵ķΰ©(P<0£®01)¡£p53¿¹ÌåµÄÌØÒìÐÔΪ100£¥£¬NSE¡¢pro-GRP¶ÔСϸ°û·Î°©¼ì²âµÄÃô¸ÐÐÔÃ÷ÏÔ¸ßÓÚÆäËûÀàÐ͵ķΰ©(P<0£®01)£¬CYFRA21¡ª1¶ÔÁÛ°©¼ì²âµÄÃô¸ÐÐÔÃ÷ÏÔ¸ßÓÚÆäËûÀàÐ͵ķΰ©(P<0£®O1)¡£5ÖÖѪÇåÖ×Áö±êÖ¾Îï¾­×éºÏºó£¬Ãô¸ÐÐÔÃ÷ÏÔ¸ßÓÚÈÎÒ»µ¥ÏîÖ×Áö±êÖ¾Îï(P<0£®01)¡£
½áÂÛ
5ÖÖѪÇåÖ×Áö±êÖ¾Îï¶ÔÓڷΰ©µÄ¸¨ÖúÕï¶ÏÓÐÒ»¶¨µÄÁÙ´²ÒâÒå¡£NSE¡¢pro-GRP¶þÕß¿É×÷ΪÁªºÏ¼ì²âСϸ°û·Î°©µÄÊ×Ñ¡±êÖ¾ÎCYFRA21¡ª1¡¢CEAºÍp53¿¹ÌåÈýÕß¿É×÷ΪÁªºÏ¼ì²â·ÇСϸ°û·Î°©µÄÊ×Ñ¡±êÖ¾Îï¡£p53¿¹Ìå¶Ô·Î°©µÄ¸¨ÖúÕï¶ÏÓкܸߵÄÌØÒìÐÔ£¬CYFRA21¡ª1¶ÔÁÛ°©µÄ¸¨ÖúÕï¶ÏÓÐÒ»¶¨µÄ×÷Óá£
¡¾Ö÷Ìâ´Ê¡¿Ö×Áö±êÖ¾Î·ÎÖ×Áö£¯Õï¶Ï£»·ÇСϸ°û·Î°©£¯Õï¶Ï

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

_¨ŠÈô¡§|ÏàÒÀ

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
°®ÓëÓêÏÂ: ½ð±Ò+2 2012-04-29 08:05:09
°®ÓëÓêÏÂ: , »¶Ó­³£À´~£¡ 2012-04-29 08:05:19
zhuimenglx: ½ð±Ò+100, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú, лл£¡ 2012-05-01 15:22:11
Application of tumor markers in serum in the assisted diagnosis of lung cancerPurposeExplore the application value of five kinds of serum tumor markers in assisted diagnosis of lung cancer , and select the best combination of serum tumor markers .Method we used the Enzyme-linked immunosorbent assay ( EL1SA ) to detecte the neuron-specific enolase (NSE) in serum  , gastrin-releasing peptide precursor (pro - GRP) the cytokeratin l9 ( CYFRA21 -1 ) , p53 antibody and  the level of content of carcinoembryonic antigen (CEA).All of above are from 170 cases of lung cancer patients and 50 healthy controls and 60 cases of patients with benign lung disease
ResultThe level of five kinds of  tumor markers in serum from lung cancer patients were significantly higher than the group of healthy individuals and benign lung disease group , the difference was statistically significant ( P <0.01 ) . The level of NSE and pro -GRP of in small cell of lung cancer was significantly higher than other types of lung cancer ( P <0.01 ) , the level of CYFRA21 -1 in squamous cancer was significantly higher than other types of lung cancer ( P <0.01 ) .The specificity of p53 antibody was 100 %, the sensitivity that using NSE, pro -GRP to detect small cell lung cancer was significantly higher than other types of lung cancer ( P <0.01 ) , the sensitivity that using CYFRA21 -1 to detect squamous carcinoma was significantly higher than other types of lung cancer ( P < 0.01 ) . After the combination of Five kinds of serum tumor markers , the sensitivity was significantly higher than any of the individual tumor markers ( P <0.01 ) .
Conclusion Five kinds of serum tumor marker have a certain clinical significances for assisted diagnosis of lung cancer. NSE and pro -GRP can be used asr forof small cell lung cancer , CYFRA21 -1 , CEA and p53 antibody can be used as the preferred marker for joint detection of non-small cell lung cancer . p53 antibody has a high specificity for assisted diagnosis of lung cancer ,CYFRA21 - 1 has a certain effects on assisted diagnosis of squamous cancer
¡¾Keywords ¡¿ tumor markers ; lung neoplasms / diagnosis ; non - small cell lung cancer / diagnosis
ÈçÈôÕâ°ã£¬µ±³õÓÖΪÁËʲô£¿
2Â¥2012-04-28 21:13:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zhuimenglx µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á +10 Áº¸»¹óÏÕÖÐÇó 2026-04-04 12/600 2026-04-05 09:37 by guoweigw
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á +12 ²×º£ÇáÖÛe 2026-04-03 13/650 2026-04-04 23:45 by lqwchd
[¿¼ÑÐ] 294Çóµ÷¼Á +6 Grey_Ey 2026-04-02 9/450 2026-04-04 22:07 by hemengdong
[¿¼ÑÐ] 296²ÄÁÏר˶Çóµ÷¼Á +21 202451007219 2026-04-02 22/1100 2026-04-04 21:48 by hemengdong
[¿¼ÑÐ] 321Çóµ÷¼Á +13 ÈÏÕæÇóÉÏѧ 2026-04-02 13/650 2026-04-04 18:23 by macy2011
[¿¼ÑÐ] Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-04 3/150 2026-04-04 12:19 by Éá¶øºóµÃ
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸±±Àí325·ÖÇóµ÷¼Á +6 ÕÒµ÷¼Á£¬£¬ 2026-04-02 6/300 2026-04-03 22:20 by –¹Æ?
[¿¼ÑÐ] 281Çóµ÷¼Á +10 aaawhy 2026-04-03 10/500 2026-04-03 21:42 by lbsjt
[¿¼ÑÐ] Çóµ÷¼Á +8 akdhjs 2026-04-03 8/400 2026-04-03 18:17 by ´÷άING
[¿¼ÑÐ] Çóµ÷¼Á²»Ìôרҵ +3 xrh030412 2026-04-01 3/150 2026-04-03 14:40 by µªÆøÆøÆø
[¿¼ÑÐ] 262Çóµ÷¼Á +6 ÀøÖ¾Ò»¶¨·¢ÎÄÕ 2026-04-02 7/350 2026-04-03 09:54 by linyelide
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö +3 ÄÏɽÄÏ@ 2026-04-01 3/150 2026-04-02 12:09 by xiaoranmu
[¿¼ÑÐ] 085600£¬321·ÖÇóµ÷¼Á +13 ´ó²öС×Ó 2026-03-31 13/650 2026-04-01 12:35 by chemdavid
[˶²©¼ÒÔ°] ²©Ò»±»ËͳöÁªÅà¸Ð¾õ²»ÊÊÓ¦Ôõô°ì +3 È«´åµÄ¹· 2026-03-31 3/150 2026-04-01 10:44 by 328838485
[¿¼ÑÐ] 301Çóµ÷¼Á +8 axibli 2026-04-01 8/400 2026-04-01 09:51 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] ¿¼Ñе÷¼ÁÇóÖú +7 13287130938 2026-03-31 7/350 2026-03-31 16:39 by 690616278
[»ù½ðÉêÇë] ÃæÉÏ5BÄÜÉÏ»áÂ𣿠+8 redcom 2026-03-29 8/400 2026-03-31 15:53 by niuailing
[¿¼²©] ²ÄÁÏרҵÉ격 +5 ¶ÅÓêæÃdyt 2026-03-29 5/250 2026-03-31 11:19 by oooqiao
[¿¼ÑÐ] ¸£½¨Àí¹¤´óѧ²ÄÁÏѧԺÏȽøºÏ½ðÍŶÓÕÐÊÕ¿¼Ñе÷¼ÁѧÉú +3 ´ó»ª½ðÉ̶¼ 2026-03-30 4/200 2026-03-31 01:04 by ·½Ó¢¿¡602
[¿¼ÑÐ] 0703»¯Ñ§321·ÖÇóµ÷¼Á +10 Èýdd. 2026-03-30 11/550 2026-03-30 19:24 by markhwc
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û